ZBH

Zimmer Biomet Holdings

Healthcare Medical Devices NYSE

About the company

Zimmer Biomet is a global leader in the field of orthopedics, specializing in the design, manufacturing, and marketing of innovative reconstructive implants, surgical supplies, and equipment for orthopedic surgeries. The company's commitment to excellence and advanced technology has enabled it to secure a leading market share in the United States, Europe, and Japan, making it a trusted name in the industry. The journey to success for Zimmer Biomet began with the acquisition of Centerpulse in 2003, a move that significantly strengthened their position in the market. Centerpulse was a renowned orthopedic implant manufacturer with a range of high-quality products. By incorporating Centerpulse into their portfolio, Zimmer Biomet gained access to a broader customer base and enhanced their product offerings. In 2015, Zimmer Biomet made another significant strategic move by acquiring Biomet, a well-established orthopedic company known for its comprehensive range of innovative implants and surgical solutions. This acquisition further solidified Zimmer Biomet's position as a leader in the global reconstructive market. The company's revenue streams are diverse, with approximately 70% of total revenue derived from the sales of large joints. These large joint implants, such as hip and knee replacements, are in high demand due to the increasing prevalence of joint-related conditions and an aging population. Zimmer Biomet's commitment to quality and patient satisfaction has made them a preferred choice for orthopedic surgeons and patients worldwide. Another substantial portion, roughly a quarter of their revenue, comes from extremities, trauma, and related surgical products. This segment encompasses a wide range of products, including implants, instruments, and devices used in surgeries related to hands, wrists, feet, and ankles. Zimmer Biomet's expertise in this area allows them to provide comprehensive solutions for patients who require specialized orthopedic care. Zimmer Biomet's success can be attributed to its continuous investment in research and development. The company remains at the forefront of technology, constantly striving to improve existing products and develop new, innovative solutions. Their commitment to innovation has resulted in the introduction of groundbreaking products that offer better outcomes and faster recovery times for patients. Furthermore, Zimmer Biomet works closely with healthcare professionals to provide comprehensive training and education programs. These initiatives not only assist surgeons in staying updated with the latest techniques but also ensure that patients receive the best possible care throughout their orthopedic journey. With a worldwide presence, Zimmer Biomet has a dedicated and skilled workforce that strives to make a positive impact on patients' lives. By placing patients at the center of everything they do, Zimmer Biomet continues to push boundaries and set new standards in orthopedic healthcare. In conclusion, Zimmer Biomet's steadfast commitment to innovation, strategic acquisitions, and a diverse product portfolio has positioned the company as a global leader in the orthopedic industry. With its focus on superior quality, cutting-edge technology, and patient-centric care, Zimmer Biomet is shaping the future of orthopedic reconstructive implants and surgical solutions.

Website: https://www.zimmerbiomet.com

Data updated: June 2, 2026

Sector comparison

We compare this company with the typical (middle) company in the same industry to show how it looks against similar businesses. This is information, not a recommendation.

Healthcare · 1346 peers in sector

Metric ZBH Sector median Vs. industry
P/E 21.49 20.10 ↑ Above average
EPS 3.86 USD -1.14 USD ↑ Above average
Dividend yield 1.17% 0.00% ↑ Above average
Profit margin 9.05% 0.00% ↑ Above average
ROE 6.07% -58.84% ↑ Above average

Higher and lower here are only a comparison with the typical company in the industry — a higher or lower value on its own does not mean better or worse.

Financial statements & historical data

Income statements, balance sheets, cash flow, earnings and dividend history are available for registered users

Sign up for free

AI Summary

AI-generated company analysis is available for registered users.

Sign up for free

Where does this data come from?

Frequently Asked Questions

What is Zimmer Biomet Holdings?
Zimmer Biomet is a global leader in the field of orthopedics, specializing in the design, manufacturing, and marketing of innovative reconstructive implants, surgical supplies, and equipment for orthopedic surgeries. The company's commitment to excellence and advanced technology has enabled it to secure a leading market share in the United States, Europe, and Japan, making it a trusted name in the industry. The journey to success for Zimmer Biomet began with the acquisition of Centerpulse in 2003, a move that significantly strengthened their position in the market. Centerpulse was a renowned orthopedic implant manufacturer with a range of high-quality products. By incorporating Centerpulse into their portfolio, Zimmer Biomet gained access to a broader customer base and enhanced their product offerings. In 2015, Zimmer Biomet made another significant strategic move by acquiring Biomet, a well-established orthopedic company known for its comprehensive range of innovative implants and surgical solutions. This acquisition further solidified Zimmer Biomet's position as a leader in the global reconstructive market. The company's revenue streams are diverse, with approximately 70% of total revenue derived from the sales of large joints. These large joint implants, such as hip and knee replacements, are in high demand due to the increasing prevalence of joint-related conditions and an aging population. Zimmer Biomet's commitment to quality and patient satisfaction has made them a preferred choice for orthopedic surgeons and patients worldwide. Another substantial portion, roughly a quarter of their revenue, comes from extremities, trauma, and related surgical products. This segment encompasses a wide range of products, including implants, instruments, and devices used in surgeries related to hands, wrists, feet, and ankles. Zimmer Biomet's expertise in this area allows them to provide comprehensive solutions for patients who require specialized orthopedic care. Zimmer Biomet's success can be attributed to its continuous investment in research and development. The company remains at the forefront of technology, constantly striving to improve existing products and develop new, innovative solutions. Their commitment to innovation has resulted in the introduction of groundbreaking products that offer better outcomes and faster recovery times for patients. Furthermore, Zimmer Biomet works closely with healthcare professionals to provide comprehensive training and education programs. These initiatives not only assist surgeons in staying updated with the latest techniques but also ensure that patients receive the best possible care throughout their orthopedic journey. With a worldwide presence, Zimmer Biomet has a dedicated and skilled workforce that strives to make a positive impact on patients' lives. By placing patients at the center of everything they do, Zimmer Biomet continues to push boundaries and set new standards in orthopedic healthcare. In conclusion, Zimmer Biomet's steadfast commitment to innovation, strategic acquisitions, and a diverse product portfolio has positioned the company as a global leader in the orthopedic industry. With its focus on superior quality, cutting-edge technology, and patient-centric care, Zimmer Biomet is shaping the future of orthopedic reconstructive implants and surgical solutions.
Are Zimmer Biomet Holdings shares expensive?
The price-to-earnings (P/E) ratio of Zimmer Biomet Holdings is 21.49 — the share price is 21.49 times the annual profit per share. That is higher than the typical company in the same industry (industry median: 20.10). This is information, not a recommendation. (as of 2026-06-02)
How big is Zimmer Biomet Holdings?
The market capitalization of Zimmer Biomet Holdings — the combined value of all its shares — is 16.05 B USD. The higher the market cap, the larger the company. (as of 2026-06-02)
Does Zimmer Biomet Holdings pay dividends?
The dividend yield of Zimmer Biomet Holdings is 1.17% — it shows the annual dividend relative to the share price. This is information, not a recommendation. (as of 2026-06-02)
What sector does Zimmer Biomet Holdings belong to?
Zimmer Biomet Holdings operates in the Healthcare sector, industry: Medical Devices.

What do you gain?

With Ecrumen you gain full control over your investments and assets!

All your assets
Stock market investments, real estate, bonds. Be aware of what you have in your portfolio!
AI at the service of your investments
Analyze and optimize your investments using the latest technologies. Sentiments, analyses, tips, reports. Always with up-to-date data!
A community eager to help
Find a place with people similar to you. Share your opinions, see how others manage their investments. Get help with the problems that bother you!
What do you gain?

Want to stay up to date?

Subscribe to our newsletter to stay up to date with Ecrumena news and market information. No spam, unsubscribe in one click.

For more information, please refer to our terms of use.

0/120